Congress has released its proposed FY 2026 budget for the Department of Health and Human Services (HHS), including funding for the Substance Abuse and Mental Health Services Administration (SAMHSA). The bill advanced out of the House Appropriations Committee with bipartisan support, signaling a strong likelihood of passage in the House.
For the addiction, treatment, prevention, and recovery community, the most notable takeaway is stability. The House proposal rejects the significant funding reductions floated earlier by the Administration, including a proposed 40% cut to certain federal health agencies. Instead, funding levels for HHS and SAMHSA are largely held in line with the prior fiscal year, reducing immediate disruption to prevention, treatment, harm reduction, and recovery infrastructure.
Equally important, the legislation preserves SAMHSA as a stand-alone agency. This decision addresses widespread concerns across the substance use and mental health fields that merging SAMHSA into a larger, multi-mission agency could dilute focus, expertise, and accountability at a time when overdose deaths, polysubstance use, and workforce strain remain urgent challenges.
The HHS bill is part of a broader appropriations package covering more than 70% of federal discretionary spending, with a narrow timeline to avoid a funding lapse. While final passage still requires Senate action later this month, congressional leadership has indicated intent to move the package forward.
For the Rx Summit audience, this budget proposal signals continuity rather than contraction—maintaining the federal foundation that supports evidence-based treatment, prevention, recovery supports, data systems, and community-level responses as the field navigates an evolving drug landscape and policy environment.
To read the press release, CLICK HERE.